JNJ-26489112

DB15203InvestigationalSmall molecule

JNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy).

Formula / weight: C₉H₁₁ClN₂O₄S · 278.71 g/mol (avg)
Code names: JNJ-26489112

Resolves to

Compound

UNIIG1TI012DLTCAS871824-55-4ChEMBLCHEMBL3092995

Structure

InChIKeyKXSAIQPPGSSNKX-ZETCQYMHSA-NSMILESNS(=O)(=O)NC[C@H]1COC2=C(O1)C=CC(Cl)=C2

What you can answer from here — as of April 23, 2025

809Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of JNJ-26489112, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account